INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
141 hedge funds and large institutions have $691M invested in Infinity Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 58 increasing their positions, 29 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
141
Holders Change
-2
Holders Change %
-1.4%
% of All Funds
3.76%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
28
Increased
58
Reduced
29
Closed
29
Calls
$6.98M
Puts
$5.1M
Net Calls
+$1.88M
Net Calls Change
+$11.9M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.7M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$14.9M |
| 3 |
Goldman Sachs
New York
|
+$12.6M |
| 4 |
State Street
Boston,
Massachusetts
|
+$8.68M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$7.81M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.8M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$10.6M |
| 3 |
BC
Broadfin Capital
New York
|
-$7.6M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$6.97M |
| 5 |
O
OrbiMed
New York
|
-$6.6M |
